K. Ligier, A. Belot, and G. Launoy, Descriptive epidemiology of upper aerodigestive tract cancers in France: Incidence over 1980-2005 and projection to 2010, Oral Oncol, vol.47, issue.4, pp.302-307, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00698021

, Guide -Affection longue durée -Cancer des voies aérodigestives supérieures. Haute Autorité Santé Guid ALD 30, 2009.

A. K. Chaturvedi, W. F. Anderson, and J. Lortet-tieulent, Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers, J Clin Oncol, vol.31, issue.36, pp.4550-4559, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01261786

E. P. Simard, L. A. Torre, and A. Jemal, International trends in head and neck cancer incidence rates: Differences by country, sex and anatomic site, Oral Oncol, vol.50, issue.5, pp.387-403, 2014.

K. S. Louie, H. Mehanna, and P. Sasieni, Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025, Oral Oncol, vol.51, issue.4, pp.341-348, 2015.

G. D'souza, A. R. Kreimer, and R. Viscidi, Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer, N Engl J Med, vol.356, pp.1944-1956, 2007.

M. L. Gillison, Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers, J Natl Cancer Inst, vol.92, issue.9, 2000.

A. K. Chaturvedi, E. A. Engels, and R. M. Pfeiffer, Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States, J Clin Oncol, vol.29, issue.32, pp.4294-4301, 2011.

A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi, Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review, Cancer Epidemiol Biomarkers Prev, vol.14, issue.2, pp.467-475, 2005.

B. G. Hansson, K. Rosenquist, and A. Antonsson, Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden, Acta Otolaryngol, vol.125, issue.12, pp.1337-1344, 2005.

S. Habbous, K. P. Chu, and H. Lau, Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation, CMAJ, vol.189, issue.32, 2017.

V. Bouvard, R. Baan, and K. Straif, A review of human carcinogens--Part B: biological agents, Lancet Oncol, vol.10, issue.4, pp.321-322, 2009.

, el-Naggar AK, Westra WH. p16 EXPRESSION AS A SURROGATE MARKER FOR HPV-RELATED OROPHARYNGEAL CARCINOMA: A GUIDE FOR INTERPRETATIVE RELEVANCE AND CONSISTENCY, Head Neck, vol.13, issue.10, p.1391, 2012.

N. F. Schlecht, M. Brandwein-gensler, and G. J. Nuovo, A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer, Mod Pathol, vol.24, issue.10, pp.1295-1305, 2011.

R. C. Jordan, M. W. Lingen, and B. Perez-ordonez, Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials, Am J Surg Pathol, vol.36, issue.7, pp.945-954, 2012.

J. S. Lewis, p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma, Head Neck Pathol, vol.6, issue.1, pp.75-82, 2012.

M. Evans, R. Newcombe, and A. Fiander, Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population, BMC Cancer, vol.13, issue.9, p.220, 2013.

C. Ndiaye, M. Mena, and L. Alemany, HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: A systematic review and meta-analysis, Lancet Oncol, vol.15, issue.12, pp.70471-70472, 2014.

H. Razzaghi, M. Saraiya, T. D. Thompson, S. J. Henley, L. Viens et al., Five-year relative survival for human papillomavirus-associated cancer sites, Cancer, vol.124, issue.1, pp.203-211, 2018.

L. St-guily, J. Rousseau, A. Baujat, and B. , Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study, Oral Oncol, vol.67, pp.29-36, 2017.

J. L. St-guily, A. Jacquard, and J. Prétet, Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France-The EDiTH VI study, J Clin Virol, vol.51, issue.2, pp.100-104, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00601953

M. L. Gillison, D. Souza, G. Westra, and W. , Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers, J Natl Cancer Inst, vol.100, issue.6, pp.407-420, 2008.

M. L. Gillison, A. K. Chaturvedi, W. F. Anderson, and C. Fakhry, Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma, J Clin Oncol, vol.33, issue.29, pp.3235-3242, 2015.

A. Carlander, G. Larsen, C. Jensen, and D. H. , Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014, Eur J Cancer, vol.70, pp.75-82, 2017.

A. K. Chaturvedi, E. A. Engels, and R. M. Pfeiffer, Human papillomavirus and rising oropharyngeal cancer incidence in the United States, J Clin Oncol, vol.29, issue.32, pp.4294-4301, 2011.

M. H. Stenmark, D. Shumway, and C. Guo, Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States, Laryngoscope, vol.127, issue.10, pp.2270-2278, 2017.

D. Urban, J. Corry, and D. Rischin, What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?, Cancer, vol.120, issue.10, pp.1462-1470, 2014.

M. R. Posner, J. H. Lorch, and O. Goloubeva, Survival and human papillomavirus in oropharynx cancer in TAX 324: A subset analysis from an international phase III trial, Ann Oncol, vol.22, issue.5, pp.1071-1077, 2011.

C. H. , Beauvillain de Montreuil. Cancer de l'oropharynx -Société Française de Carcinologie Cervico-Faciale

. Jl-f, Traitement des cancers de l'arrière-gorge. Mémoire original. In: Annales Des Maladies de l'oreille et Du Larynx, TXXIX, vol.3, pp.213-219, 1903.

, The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group, N Engl J Med, vol.324, issue.24, pp.1685-1690, 1991.

, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) -Head and Neck Cancers. Version 2

R. W. Hinerman, J. T. Parsons, W. M. Mendenhall, S. P. Stringer, N. J. Cassisi et al., External beam irradiation alone or combined with neck dissection for base of tongue carcinoma: an alternative to primary surgery, Laryngoscope, vol.104, issue.12, pp.1466-1470, 1994.

W. M. Mendenhall, S. P. Stringer, R. J. Amdur, R. W. Hinerman, G. J. Moore-higgs et al., Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue?, J Clin Oncol, vol.18, issue.1, pp.35-42, 2000.

W. M. Mendenhall, R. J. Amdur, S. P. Stringer, D. B. Villaret, and N. J. Cassisi, Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery?, J Clin Oncol, vol.18, issue.11, pp.2219-2225, 2000.

H. ?. Erkal, M. Serin, R. J. Amdur, D. B. Villaret, S. P. Stringer et al., Squamous cell carcinomas of the soft palate treated with radiation therapy alone or followed by planned neck dissection, Int J Radiat Oncol, vol.50, issue.2, pp.1578-1587, 2001.

A. S. Denittis, M. Machtay, and D. I. Rosenthal, Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment, Am J Otolaryngol, vol.22, issue.5, pp.329-335, 2001.

J. T. Parsons, W. M. Mendenhall, and S. P. Stringer, Squamous cell carcinoma of the oropharynx: Surgery, radiation therapy, or both, Cancer, vol.94, issue.11, pp.2967-2980, 2002.

W. M. Mendenhall, C. G. Morris, R. J. Amdur, R. W. Hinerman, J. W. Werning et al., Definitive radiotherapy for squamous cell carcinoma of the base of tongue, Am J Clin Oncol, vol.29, issue.1, pp.32-39, 2006.

B. S. Chera, R. J. Amdur, and R. W. Hinerman, Definitive radiation therapy for squamous cell carcinoma of the soft palate, Head Neck, vol.30, issue.8, pp.1114-1119, 2008.

A. P. Polednak, Growth of the Epidemic of Human Papillomavirus-Related Oropharyngeal Carcinomas in Whites in Selected US Metropolitan and Nonmetropolitan Counties, 1992-2013, J Registry Manag, vol.44, issue.1, pp.4-10, 2017.

N. Osazuwa-peters, M. C. Simpson, S. T. Massa, A. Boakye, E. Antisdel et al., 40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States, Oral Oncol, vol.74, pp.90-97, 2017.

U. C. Megwalu, D. Sirjani, and E. E. Devine, Oropharyngeal squamous cell carcinoma incidence and mortality trends in the United States, Laryngoscope, 1973.

A. P. Stein, S. Saha, M. Yu, R. J. Kimple, and P. F. Lambert, Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time, Chem Res Toxicol, vol.27, issue.4, pp.462-469, 2014.

M. A. Blasco, P. F. Svider, and T. Tenbrunsel, Recent trends in oropharyngeal cancer funding and public interest, Laryngoscope, vol.127, issue.6, pp.1345-1350, 2017.

J. Gilbert, M. L. Gillison, and R. I. Haddad, NCCN Guidelines Version 2.2016 Panel Members Head and Neck Cancers, 2016.

H. Mehanna, A. Kong, and S. Ahmed, Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines, J Laryngol Otol, vol.130, issue.S2, 2016.

B. A. Shah, M. M. Qureshi, and S. Jalisi, Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines, Pract Radiat Oncol, vol.6, issue.4, pp.248-254, 2016.

C. Fakhry, Q. Zhang, and P. F. Nguyen-tan, Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma, J Clin Oncol, vol.32, issue.30, pp.3365-3373, 2014.

S. Marur, D. Souza, G. Westra, W. H. Forastiere, and A. A. , HPV-associated head and neck cancer: a virus-related cancer epidemic, Lancet Oncol, vol.11, issue.8, pp.70017-70023, 2010.

K. K. Ang, J. Harris, and R. Wheeler, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, vol.363, issue.1, pp.24-35, 2010.

D. Rischin, R. J. Young, and R. Fisher, Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial, J Clin Oncol, vol.28, issue.27, pp.4142-4148, 2010.

C. Fakhry, W. H. Westra, and S. Li, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, J Natl Cancer Inst, vol.100, issue.4, pp.261-269, 2008.

H. Mirghani, F. Amen, and P. Blanchard, Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives, Int J Cancer, vol.136, issue.7, pp.1494-1503, 2015.
DOI : 10.1002/ijc.28847

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.28847

J. R. Kelly, Z. A. Husain, and B. Burtness, Treatment de-intensification strategies for head and neck cancer, Eur J Cancer, vol.68, pp.125-133, 2016.
DOI : 10.1016/j.ejca.2016.09.006

URL : http://europepmc.org/articles/pmc5734050?pdf=render

M. Mañós, J. Giralt, and A. Rueda, Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1), Oral Oncol, vol.70, pp.58-64, 2017.

D. Goldenberg, S. Begum, and W. H. Westra, Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon, Head Neck, vol.30, issue.7, pp.898-903, 2008.
DOI : 10.1002/hed.20796

C. Fakhry, W. H. Westra, and S. Li, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, J Natl Cancer Inst, vol.100, issue.4, pp.261-269, 2008.

J. S. Lewis, W. L. Thorstad, and R. D. Chernock, p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status, Am J Surg Pathol, vol.34, issue.8, pp.1088-1096, 2010.

P. Lassen, J. G. Eriksen, and A. Krogdahl, The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial, Radiother Oncol, vol.100, issue.1, pp.49-55, 2011.

J. A. Bonner, R. Mesia, and J. Giralt, What Is the Evidence? Oncologist. 2017:theoncologist.2016-0433

J. H. Vermorken and . Papillomavirus, A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck? In: Recent Results in Cancer Research, Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer, vol.206, pp.137-147

J. R. Cracchiolo, S. S. Baxi, and L. G. Morris, Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base, Cancer, vol.122, issue.10, pp.1523-1532, 2016.

J. Howard, L. Masterson, and R. C. Dwivedi, Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma, Cochrane database Syst Rev, vol.12, p.10963, 2016.
DOI : 10.1002/14651858.cd010963.pub2

P. Gorphe, P. Blanchard, S. Morinière, and N. Fakhry, Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey, Eur Arch OtoRhino-Laryngology, vol.273, issue.8, pp.2201-2207, 2016.
DOI : 10.1007/s00405-015-3744-0

S. C. Kamran, M. M. Qureshi, S. Jalisi, A. Salama, G. Grillone et al., Primary surgeryversus primary radiation-based treatment for locally advanced oropharyngeal cancer, Laryngoscope, vol.2017, pp.1-12
DOI : 10.1002/lary.26903

K. Soo, E. Tan, and J. Wee, Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison, Br J Cancer, vol.93, issue.3, pp.279-286, 2005.

A. S. Allal, K. Nicoucar, N. Mach, and P. Dulguerov, Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy, Head Neck, vol.25, issue.10, pp.833-842, 2003.

L. B. Harrison, M. J. Zelefsky, J. G. Armstrong, E. Carper, J. J. Gaynor et al., Performance status after treatment for squamous cell cancer of the base of tongue-A comparison of primary radiation therapy versus primary surgery, Int J Radiat Oncol, vol.30, issue.4, pp.90371-90380, 1994.

S. Song, H. G. Wu, and C. G. Lee, Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study, BMC Cancer, vol.17, issue.1, pp.1-8, 2017.
DOI : 10.1186/s12885-017-3571-3

URL : https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3571-3

H. Mirghani and J. L. Saint-guily, Papillomavirus humain et cancer de l'oropharynx

D. Fonmarty, S. Cherrière, and H. Fleury, Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma, Eur Ann Otorhinolaryngol Head Neck Dis, vol.132, issue.3, pp.135-139, 2015.

R. Granata, R. Miceli, and E. Orlandi, Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study, Ann Oncol, vol.23, issue.7, pp.1832-1837, 2012.

C. De-martel, M. Plummer, J. Vignat, and S. Franceschi, Worldwide burden of cancer attributable to HPV by site, country and HPV type, Int J cancer, vol.141, issue.4, pp.664-670, 2017.

R. Lucas-roxburgh, J. Benschop, B. Lockett, U. Van-den-heever, R. Williams et al., The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population. Tornesello ML, ed. PLoS One, vol.12, p.186424, 2017.

G. H. Fossum, A. K. Lie, P. Jebsen, L. E. Sandlie, and J. Mork, Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival. Eur Arch Oto-Rhino-Laryngology, vol.274, pp.4003-4010, 2017.
DOI : 10.1007/s00405-017-4748-8

M. G. Donà, G. Spriano, and B. Pichi, Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014, Future Microbiol, vol.10, issue.8, pp.1283-1291, 2015.

P. Morbini and M. Benazzo, Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data, Acta Otorhinolaryngol Ital, vol.36, issue.4, pp.249-258, 2016.

M. Mena, M. Taberna, and S. Tous, Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients, Oral Oncol, vol.78, pp.137-144, 2018.

L. St-guily, J. Rousseau, A. Baujat, and B. , Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study, Oral Oncol, vol.67, pp.29-36, 2017.

G. Gao, R. D. Chernock, and H. A. Gay, A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis, Int J cancer, vol.132, issue.4, pp.882-890, 2013.

G. Larsen, C. Gyldenløve, M. Jensen, and D. H. , Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review, Br J Cancer, vol.110, issue.6, pp.1587-1594, 2014.

F. Perrone, A. Gloghini, and B. Cortelazzi, Isolating p16-positive/`HPV-negative oropharyngeal cancer : an effort worth making, Am J Surg Pathol, vol.35, issue.5, pp.774-777, 2011.
DOI : 10.1097/pas.0b013e3182116a45

S. H. Huang and B. O'sullivan, Overview of the 8th Edition TNM Classification for Head and Neck Cancer, Curr Treat Options Oncol, vol.18, issue.7, 2017.

M. L. Gillison, D. Souza, G. Westra, and W. , Distinct Risk Factor Profiles for Human Papillomavirus Type 16?Positive and Human Papillomavirus Type 16?Negative Head and Neck Cancers, JNCI J Natl Cancer Inst, vol.100, issue.6, pp.407-420, 2008.
DOI : 10.1093/jnci/djn025

URL : https://academic.oup.com/jnci/article-pdf/100/6/407/17310069/djn025.pdf

M. Canis, A. Martin, and M. Kron, Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil, Eur Arch Otorhinolaryngol, vol.270, issue.8, pp.2299-2306, 2013.

G. Yildirim, W. H. Morrison, and D. I. Rosenthal, Outcomes of patients with tonsillar carcinoma treated with post-tonsillectomy radiation therapy, Head Neck, vol.32, issue.4, pp.473-480, 2010.
DOI : 10.1002/hed.21207

M. Poulsen, S. V. Porceddu, P. A. Kingsley, L. Tripcony, and W. Coman, Locally Advanced Tonsillar Squamous Cell Carcinoma: Treatment Approach Revisited, Laryngoscope, vol.117, issue.1, pp.45-50, 2007.
DOI : 10.1097/01.mlg.0000243044.91193.32

S. Wagner, C. Wittekindt, and S. J. Sharma, Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer, Br J Cancer, vol.116, issue.12, pp.1604-1611, 2017.

N. Wuerdemann, C. Wittekindt, and S. J. Sharma, Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer, Oncol Res Treat, vol.40, issue.6, pp.320-327, 2017.

D. F. Roden, D. Schreiber, and B. Givi, Triple-modality treatment in patients with advanced stage tonsil cancer, Cancer, vol.123, issue.17, pp.3269-3276, 2017.

B. O. Sullivan, S. H. Huang, and L. L. Siu, Deintensification Candidate Subgroups in Human Papillomavirus -Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis, J Clin Oncol, vol.31, issue.5, pp.543-550, 2013.

N. J. Farsi, M. Rousseau, and N. Schlecht, Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol, Carcinogenesis, vol.38, issue.12, pp.1188-1195, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01854470

A. Bozec, P. Demez, and J. Gal, Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: A GETTEC prospective multicentric study, Surg Oncol, vol.27, issue.1, pp.23-30, 2018.

S. G. Shiley, C. A. Hargunani, J. M. Skoner, J. M. Holland, and M. K. Wax, Swallowing function after chemoradiation for advanced stage oropharyngeal cancer, Otolaryngol Head Neck Surg, vol.134, issue.3, pp.455-459, 2006.

J. M. Skoner, P. E. Andersen, J. I. Cohen, J. J. Holland, E. Hansen et al., Swallowing function and tracheotomy dependence after combined-modality treatment including free tissue transfer for advanced-stage oropharyngeal cancer, Laryngoscope, vol.113, issue.8, pp.1294-1298, 2003.

T. Brown, M. Banks, B. Hughes, C. Lin, L. M. Kenny et al., Impact of early prophylactic feeding on long term tube dependency outcomes in patients with head and neck cancer, Oral Oncol, vol.72, pp.17-25, 2017.

P. Boscolo-rizzo, M. Stellin, R. Fuson, C. Marchiori, A. Gava et al., Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: Surgery and postoperative radiotherapy versus concurrent chemoradiation, Oral Oncol, vol.45, issue.11, pp.953-957, 2009.

M. A. O'rorke, M. V. Ellison, L. J. Murray, M. Moran, J. James et al., Human papillomavirus related head and neck cancer survival: A systematic review and metaanalysis, Oral Oncol, vol.48, issue.12, pp.1191-1201, 2012.

J. R. Kelly, H. S. Park, and Y. An, Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer, Oral Oncol, vol.79, pp.64-70, 2017.

N. Gildener-leapman, J. Kim, and S. Abberbock, Utility of up-front transoral robotic surgery in tailoring adjuvant therapy, Head Neck, vol.38, issue.8, pp.1201-1207, 2016.

D. Rischin, R. J. Young, and R. Fisher, Prognostic significance of p16INK4Aand human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial, J Clin Oncol, vol.28, issue.27, pp.4142-4148, 2010.

M. T. Dillon and K. J. Harrington, Human papillomavirus-negative pharyngeal cancer, J Clin Oncol, vol.33, issue.29, pp.3251-3261, 2015.

J. R. Kelly, H. S. Park, and Y. An, Comparison of survival outcomes among human papillomavirus-negative cT1-2 N1-2b patients with oropharyngeal squamous cell cancer treated with upfront surgery vs definitive chemoradiation therapy: An observational study, JAMA Oncol, vol.3, issue.8, pp.1107-1111, 2017.

R. J. Glynn, S. Schneeweiss, and T. Sturmer, Indications for Propensity Scores and Review of their Use in Pharmacoepidemiology, Basic Clin Pharmacol Toxicol, vol.98, issue.3, pp.253-259, 2006.

H. Mirghani, F. Amen, and P. Blanchard, Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives, Int J Cancer, vol.136, issue.7, pp.1494-1503, 2015.

, Impact Factor : 3.688) Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study, European Journal of Surgical Oncology, vol.5